Since 2005, the Master in Pharmaceutical Marketing – MAMAF has represented a solid educational reality for over a decade, dedicated to recent graduates wishing to specialize in marketing within the pharmaceutical sector.
Over the years, MAMAF has developed a comprehensive educational model integrating technical training, transversal skills, and a practical, employability-focused approach. Established partnerships with leading companies in the sector and the inclusion of expert lecturers from both the academic world and industry have helped to ensure up-to-date, high-quality content, in line with the trends and innovations of the life sciences sector.
With the changing needs of the market and the growing complexity of the healthcare and scientific context, today, with the edition named “MAMAF 3.0 – Road to 2030”, the University Master presents itself as a one-of-a-kind programme, designed to train future Managers in the Pharma, Biotech and Healthcare sectors through a blended weekend format that combines flexibility and in-depth study.
Over time, the MAMAF Master has been able to evolve and expand its training offering, becoming a programme that prepares professionals with a 360° profile, providing not only solid foundations in marketing, but also skills in market access, regulatory affairs, communication and medical affairs for comprehensive and interdisciplinary preparation in line with the new needs of the healthcare system.
Through a training programme that combines project work, practical exercises, simulations and company testimonials, MAMAF concretely prepares participants to face the real challenges of the sector, offering multiple opportunities for hands-on experience, combining the transfer of technical and strategic skills with constant support from tutors and mentors, to foster an effective entry into the world of work.
From 2005 to date, the MAMAF Master has trained 210 students, with career placement outcomes that demonstrate the solidity of the programme and its ability to meet the needs of the market.
185 graduates employed in the healthcare sector, specifically:
- 56,8% placed in pharmaceutical companies
- 32,8% employed in companies operating in the cosmetic, supplements, biomedical area
- 10,4% joined consulting firms specialised in pharma/healthcare
These results demonstrate the tangible effectiveness of the Master in preparing talented graduates ready to enter the most dynamic and competitive segments of healthcare, ensuring diverse career opportunities in line with the evolution of the sector.
The Master’s programme trains qualified professionals to analyze and evaluate processes related to market access, management, and marketing within the pharmaceutical sector, as well as healthcare and life science communication agencies and service organisations involved in planning and budgeting.
Students will develop cross-cutting skills applicable throughout the entire healthcare ecosystem.
What you will learn from the MAMAF Master’s programme::
- You will gain a comprehensive 360-degree understanding of the pharmaceutical sector, combining specialization with deep insight into key processes.
- You will enhance your communication and adaptability skills in multidisciplinary and complex environments.
- You will learn to work effectively in teams through group projects and real-life case studies, ensuring an immediate professional impact.
- You will develop technical, managerial, and digital competences to anticipate and adapt to the evolving healthcare ecosystem.
The Master’s programme prepares professionals capable of taking on coordination or consultancy roles in the following areas:
- Marketing and sales within the pharmaceutical industry
- Outsourced services for pharmaceutical marketing planning
- Specialised communication agencies in the healthcare and pharmaceutical sectors
- Pharmaceutical market research
- Medical departments
- Business development and licensing divisions
- Medical and scientific publishing
- Pharmacoeconomics, health economics, and market access
The Master’s programme has progressively expanded its educational offering to include new areas such as Market Access, Pharmaceutical Management, Communication, Digital Health, and Artificial Intelligence in Healthcare. It places strong emphasis on the development of soft skills, career guidance, and personal coaching — essential elements for successfully tackling complex challenges and working effectively within interdisciplinary teams.
After the enrolment phase (by 11 January 2026), students will begin their training journey with the start of in-person classes on 28 February 2027. This will mark the beginning of an intensive learning period led by lecturers and industry professionals, which may conclude with a full-time, in-person workshop week focused on specific thematic areas of the programme, such as:
• Winning managerial strategies: Marketing and innovation in the life science sector
• Access & Value – From evidence to impact in the healthcare system
• HealthTalk: Techniques and tools for communicating science, value and innovation
• Leading change: Management and leadership in the life science sector
• Digital connections: Digitalisation and patient experience – the new frontiers of healthcare
From June 2027, students will begin their curricular internship (625 hours), a fundamental experience for applying the knowledge and skills acquired during the study period and for establishing a first concrete connection with companies in the sector.
The Master’s programme concludes in April 2028, culminating in the presentation and discussion of the final project work.. Thanks to the competences developed and the network built during the internship, graduates will be ready to enter the job market, with targeted professional placement opportunities within the pharmaceutical industry and consulting and academic organisations linked to it.
At the end of the Master’s programme, students will be assessed based on their group work carried out during the classroom activities, the evaluation of their internship, and the final project, which consists of writing a thesis related to their personal work project. This project will address topics covered during the Master and will be conducted in collaboration with pharmaceutical companies, publishing agencies, or partner service organisations.
The final thesis will be presented either as a poster or an oral presentation, depending on the academic board’s decision. Progress evaluations and the final examination will not be graded numerically.
The final examination will consist of preparing a thesis on a topic agreed upon by the candidate, academic board, and company supervisor, reflecting the internship experience and Master’s themes..
Upon successful completion of all required activities and the final examination, participants will be awarded the Second Level University Master’s Diploma in “MAMAF 3.0 – Road to 2030. Master for Future Managers in the Pharma, Biotech and Healthcare Sectors.”
The training period cannot be suspended, and transfers to equivalent Master’s programmes at other universities are not permitted.
© 2025 Copyrights by MAMAF 3.0. All Rights Reserved